Stocks
Silk Road Medical, IncSILK
NASDAQHealthcareMedical Devices$27.49-0.04%
Specializing in minimally invasive treatments for carotid artery disease, this medtech firm focuses on reducing stroke risk through its proprietary transcarotid artery revascularization (TCAR) technology. Investors monitor Silk Road Medical for its growth potential in the $2B+ carotid stent market and ongoing clinical adoption of TCAR as an alternative to traditional surgery.
Market Cap: $1.1B52W Range: $6.08 – $27.51
Congressional Interest in Silk Road Medical, Inc (SILK)
1 member of Congress has disclosed 1 trade in Silk Road Medical, Inc (SILK), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading SILK?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-03-06 | Daniel Goldman | sell | $1K – $15K |